Hjem › Endometriekreft › Alabama › Birmingham
Kliniske studier for Endometriekreft i Birmingham, AL
16 studier for Endometriekreft søker deltakere på steder i og rundt Birmingham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
RekruttererFase 3
- GSK Investigational Site, Birmingham
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekruttererFase 3
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RekruttererFase 2
- University of Alabama at Birmingham Cancer Center, Birmingham
DESTINY-PANTUMOUR04
RekruttererObservasjonsstudie
- Research Site, Birmingham
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
RekruttererFase 1/2
- University of Alabama_6th Ave, Birmingham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- University of Alabama at Birmingham, Birmingham
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruttererFase 1
- University of Alabama Birmingham, Birmingham
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- Children's Hospital of Alabama, Birmingham
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- University of Alabama at Birmingham, Birmingham
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of Alabama at Birmingham, Birmingham
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruttererFase 1
- University of Alabama at Birmingham, Birmingham
- University of Alabama at Birmingham, IDS Pharmacy, Birmingham
- University of Alabama at Birmingham, Birmingham
- og 1 flere
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruttererFase 2
- 004, Birmingham
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
RekruttererFase 1/2
- O'Neal Comprehensive Cancer Center at UAB, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Birmingham
Endometriekreft-studier i andre byer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Chicago, IL25 studier
- Columbus, OH25 studier
- Queens, NY25 studier
Andre studier i Birmingham
- Kreft (alle typer)30 studier
- Brystkreft24 studier
- Fedme23 studier
- Eggstokkreft23 studier
- Ikke-småcellet lungekreft22 studier
- Akut myelogen leukemi21 studier
- Multipelt myelom18 studier
- KOLS17 studier
- Kardiovaskulær sykdom17 studier
- Overvekt16 studier
- Type 2-diabetes16 studier
- Cystisk fibrose16 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.